The mid-term clinical outcomes of total knee arthroplasty in the management of
end-stage hemophilic arthropathy

KALKISIM, Muhammet; Okutan, Ahmet Emin; Saraç, Ünal; Kerimoglu, Servet

doi:10.5152/j.aott.2022.21131

The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy

Muhammet Kalkışım, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Ortopedi ve Travmatoloji Anabilim Dalı, Trabzon, Türkiye)

Ahmet Emin Okutan, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Ortopedi ve Travmatoloji Anabilim Dalı, Trabzon, Türkiye)

Ünal Saraç, (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Ortopedi ve Travmatoloji Anabilim Dalı, Trabzon, Türkiye)

Servet Kerimoğlu (Karadeniz Teknik Üniversitesi, Tıp Fakültesi, Ortopedi ve Travmatoloji Anabilim Dalı, Trabzon, Türkiye)

Acta Orthopaedica et Traumatologica Turcica

0 0

Yıl: 2022 Cilt: 56 Sayı: 2 Sayfa Aralığı: 94 - 99 Metin Dili: İngilizce DOI: 10.5152/j.aott.2022.21131 İndeks Tarihi: 13-06-2022

The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy

Öz:

Objective: This study aimed to evaluate the mid-term clinical outcomes of total knee arthroplasty (TKA) in the management of end-stage hemophilic arthropathy. Methods: Eleven patients (15 knees) undergoing TKA with stiff knees were retrospectively evaluated. TKA was performed in all patients without additional surgical interventions such as posterior capsular release, hamstring release, synovectomy, VY quadricepsplasty, or tibial tubercle osteotomy. All patients were evaluated for clinical and radiological results at follow-ups. Functional evaluation and pain status were assessed using the Knee Society Score and Visual Analogue Scale. Results: The mean age at the time of operation was 40.8 ± 11.8 years (range = 30–64 years). The mean follow-up was 51.2 ± 20.6 months (range = 24–95). The mean flexion contracture significantly decreased from 17.6 ± 11.3 to 1.7 ± 2.8 degrees, and the mean maximum flex- ion increased dramatically from 55.6 ± 20.5 to 109.2 ± 16.2 degrees (P < 0.001). Statistical significant improvement in flexion and flexion contracture degrees continued up to the postoperatively 18 months. The mean Knee Society Score increased from 22.7 ± 2.4 points pre- operatively to 87.8 ± 3.8 points at the last follow-up (P < 0.001). The mean cost of coagulation factor consumption and blood transfusion accounted for 78% of the total cost. Conclusion: This study has shown that TKA is an effective treatment for relieving pain and improving both ranges of motion and quality of life in managing end-stage hemophilic arthropathy of the knee joint.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Bibliyografik

1. Rodriguez-Merchan EC. Special features of total knee replacement in hemo- philia. Expert Rev Hematol. 2013 ;6(6):637-642. [CrossRef]
2. Rodriguez-Merchan EC. Aspects of current management: orthopaedic surgery in haemophilia [internet]. Haemophilia. 2012;18(1):8-16. [CrossRef]
3. Wong JML, Mann HA, Goddard NJ. Perioperative clotting factor replacement and infection in total knee arthroplasty [internet]. Haemophilia. 2012;18(4):607- 612. [CrossRef]
4. Ernstbrunner L, Hingsammer A, Catanzaro S, et al. Long-term results of total knee arthroplasty in haemophilic patients: an 18-year follow-up. Knee Surg Sports Traumatol Arthrosc. 2017;25(11):3431-3438. [CrossRef]
5. Duffy GP, Crowder AR, Trousdale RR, Berry DJ. Cemented total knee arthro- plasty using a modern prosthesis in young patients With osteoarthritis. J Arthroplasty. 2007;22(6):67-70. [CrossRef]
6. Ernstbrunner L, Hingsammer A, Catanzaro S, et al. Long-term results of total knee arthroplasty in haemophilic patients: an 18-year follow-up. Knee Surg Sports Traumatol Arthrosc. 2017;25(11):3431-3438. [CrossRef]
7. Moore MF, Tobase P, Allen DD. Meta-analysis: outcomes of total knee arthro- plasty in the haemophilia population. Haemophilia. 2016;22(4):e275-e285. [CrossRef]
8. Mortazavi SMJ, Haghpanah B, Ebrahiminasab MM, Baghdadi T, Toogeh G. Functional outcome of total knee arthroplasty in patients with haemophilia. Haemophilia. 2016;22(6):919-924. [CrossRef]
9. Song SJ, Bae JK, Park CH, Yoo MC, Bae DK, Kim KI. Mid-term outcomes and complications of total knee arthroplasty in haemophilic arthropathy: a review of consecutive 131 knees between 2006 and 2015 in a single institute. Haemo- philia. 2018;24(2):299-306. [CrossRef]
10. Anderson JA, Mason JA, Halliday B. Clinical outcomes and patient satisfaction fol- lowing total hip and knee arthroplasty in patients with inherited bleeding disorders: a 20-year single-surgeon cohort. Haemophilia. 2018;24(5):786-791. [CrossRef]
11. Wang SH, Chung CH, Chen YC, Cooper AM, Chien WC, Pan RY. Does hemo- philia increase risk of adverse outcomes following total hip and knee arthro- plasty? A propensity score–matched analysis of a nationwide, population-based study. J Arthroplasty. 2019;34(10):2329-2336.e1. [CrossRef]
12. Kapadia BH, Boylan MR, Elmallah RK, Krebs VE, Paulino CB, Mont MA. Does hemophilia increase the risk of postoperative blood transfusion after lower extrem- ity total joint arthroplasty? J Arthroplasty. 2016;31(7):1578-1582. [CrossRef]
13. Kotani A, Yonekura A, Bourne RB. Factors influencing range of motion after contemporary total knee arthroplasty. J Arthroplasty. 2005;20(7):850-856. [CrossRef]
14. Ritter MA, Harty LD, Davis KE, Meding JB, Berend ME. Predicting range of motion after total knee arthroplasty: clustering, log-linear regression, and regression tree analysis. J Bone Jt Surg - Ser A. 2003;85(7):1278-1285.
15. Atilla B, Caglar O, Pekmezci M, Buyukasik Y, Tokgozoglu AM, Alpaslan M. Pre-operative flexion contracture determines the functional outcome of hae- mophilic arthropathy treated with total knee arthroplasty. Haemophilia. 2012;18(3):358-363. [CrossRef]
16. Wiedel J, Stabler S, Geraghty S, Funk S. Joint replacement surgery in hemo- philia. Available at: [CrossRef]. Accessed 2021 Jul 12.
17. Kamath AF, Horneff JG, Forsyth A, Nikci V, Nelson CL. Total knee arthroplasty in hemophiliacs: gains in range of motion realized beyond twelve months post- operatively. Clin Orthop Surg. 2012;4(2):121-128. [CrossRef]
18. Insall JN, Dorr LD, Scott RD, Scott WN. Rationale of the Knee Society clinical rating system. Clin Orthop Relat Res. 1989;248:13-14. [CrossRef]
19. Rickard KA. Guidelines for therapy and optimal dosages of coagulation factors for treatment of bleeding and surgery in haemophilia. Haemophilia. 1995;1(suppl 1):8-13. [CrossRef]
20. Rodriguez-Merchan EC. Correction of fixed contractures during total knee arthroplasty in haemophiliacs. Haemophilia. 1999;5(suppl 1):33-38. [CrossRef]
21. Cho KY, Kim KI, Khurana S, Cho SW, Kang DG. Computer-navigated total knee arthroplasty in haemophilic arthropathy. Haemophilia. 2013;19(2):259-266. [CrossRef]
22. Strauss AC, Schmolders J, Friedrich MJ, et al. Outcome after total knee arthro- plasty in haemophilic patients with stiff knees. Haemophilia. 2015;21(4):e300-e305. [CrossRef]
23. Silva M, Luck JV. Long-term results of primary total knee replacement in patients with hemophilia [internet]. J Bone Joint Surg Am. 2005;87(1):85-91. [CrossRef]
24. Stratford PW, Kennedy DM, Robarts SF. Modelling knee range of motion post arthroplasty: clinical applications. Physiother Can. 2010;62(4):378-387. [CrossRef]
25. Zhou Z, Yew KSA, Arul E, et al. Recovery in knee range of motion reaches a plateau by 12 months after total knee arthroplasty. Knee Surg Sports Traumatol Arthrosc. 2015;23(6):1729-1733. [CrossRef]
26. Moore MF, Tobase P, Allen DD. Meta-analysis: outcomes of total knee arthro- plasty in the haemophilia population. Haemophilia. 2016;22(4):e275-e285. [CrossRef]
27. Heeg M, Meyer K, Smid WM, Horn JR, Meer JVD. Total knee and hip arthro- plasty in haemophilic patients. Haemophilia. 1998;4(5):747-751. [CrossRef]
28. Zingg PO, Fucentese SF, Lutz W, Brand B, Mamisch N, Koch PP. Haemophilic knee arthropathy: long-term outcome after total knee replacement. Knee Surg Sports Traumatol Arthrosc. 2012:2465-2470. [CrossRef]
29. Strauss AC, Goldmann G, Schmolders J, et al. Impact of preoperative knee stiffness on the postoperative outcome after total knee arthroplasty in patients with haemophilia. Z Orthop Unfall [Internet]. 2015;153(5):526–532.
30. Vanarase MY, Pandit H, Kimstra YW, Dodd CA, Popat MT. Pain relief after knee replacement in patients with a bleeding disorder. Haemophilia. 2007;13(4):395-397. [CrossRef]
31. Feng B, Weng XS, Lin J, et al. Outcome of total knee arthroplasty combined patelloplasty for end-stage type A hemophilic arthropathy. Knee. 2012;19(2):107- 111. [CrossRef]
32. Srivastava A, Brewer AK, Mauser-Bunschoten EP, et al. Guidelines for the man- agement of hemophilia. Haemophilia. 2013;19(1):e1-e47. [CrossRef]
33. Matsen FA, Warme WJ, Jackins SE. Can the ream and run procedure improve glenohumeral relationships and function for shoulders with the arthritic triad? Clin Orthop Relat Res. 2015;473(6):2088-2096. [CrossRef]
34. Feng B, Weng XS, Lin J, et al. Outcome of total knee arthroplasty combined patelloplasty for end-stage type A hemophilic arthropathy. Knee. 2012;19(2):107- 111. [CrossRef]
35. Innocenti M, Civinini R, Carulli C, Villano M, Linari S, Morfini M. A modular total knee arthroplasty in haemophilic arthropathy. Knee. 2007;14(4):264-268. [CrossRef]
36. Rodriguez-Merchan EC. Correction of fixed contractures during total knee arthroplasty in haemophiliacs. Haemophilia. 1999;5(s1):33-38. [CrossRef]
37. Lobet S, Pendeville E, Dalzell R, et al. The role of physiotherapy after total knee arthroplasty in patients with haemophilia. Haemophilia. 2008;14(5):989-998. [CrossRef]
38. Moffet H, Collet JP, Shapiro SH, Paradis G, Marquis F, Roy L. Effectiveness of intensive rehabilitation on functional ability and quality of life after first total knee arthroplasty: a single-blind randomized controlled trial. Arch Phys Med Rehabil. 2004;85(4):546-556. [CrossRef]
39. Lizaur A, Marco L, Cebrian R. Preoperative factors influencing the range of movement AFTER total knee arthroplasty for severe osteoarthritis. J Bone Joint Surg. 1997;79-B(4):626-629. [CrossRef

APA	KALKISIM M, Okutan A, Saraç Ü, Kerimoglu S (2022). The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. , 94 - 99. 10.5152/j.aott.2022.21131
Chicago	KALKISIM Muhammet,Okutan Ahmet Emin,Saraç Ünal,Kerimoglu Servet The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. (2022): 94 - 99. 10.5152/j.aott.2022.21131
MLA	KALKISIM Muhammet,Okutan Ahmet Emin,Saraç Ünal,Kerimoglu Servet The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. , 2022, ss.94 - 99. 10.5152/j.aott.2022.21131
AMA	KALKISIM M,Okutan A,Saraç Ü,Kerimoglu S The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. . 2022; 94 - 99. 10.5152/j.aott.2022.21131
Vancouver	KALKISIM M,Okutan A,Saraç Ü,Kerimoglu S The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. . 2022; 94 - 99. 10.5152/j.aott.2022.21131
IEEE	KALKISIM M,Okutan A,Saraç Ü,Kerimoglu S "The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy." , ss.94 - 99, 2022. 10.5152/j.aott.2022.21131
ISNAD	KALKISIM, Muhammet vd. "The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy". (2022), 94-99. https://doi.org/10.5152/j.aott.2022.21131

APA	KALKISIM M, Okutan A, Saraç Ü, Kerimoglu S (2022). The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. Acta Orthopaedica et Traumatologica Turcica, 56(2), 94 - 99. 10.5152/j.aott.2022.21131
Chicago	KALKISIM Muhammet,Okutan Ahmet Emin,Saraç Ünal,Kerimoglu Servet The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. Acta Orthopaedica et Traumatologica Turcica 56, no.2 (2022): 94 - 99. 10.5152/j.aott.2022.21131
MLA	KALKISIM Muhammet,Okutan Ahmet Emin,Saraç Ünal,Kerimoglu Servet The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. Acta Orthopaedica et Traumatologica Turcica, vol.56, no.2, 2022, ss.94 - 99. 10.5152/j.aott.2022.21131
AMA	KALKISIM M,Okutan A,Saraç Ü,Kerimoglu S The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. Acta Orthopaedica et Traumatologica Turcica. 2022; 56(2): 94 - 99. 10.5152/j.aott.2022.21131
Vancouver	KALKISIM M,Okutan A,Saraç Ü,Kerimoglu S The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy. Acta Orthopaedica et Traumatologica Turcica. 2022; 56(2): 94 - 99. 10.5152/j.aott.2022.21131
IEEE	KALKISIM M,Okutan A,Saraç Ü,Kerimoglu S "The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy." Acta Orthopaedica et Traumatologica Turcica, 56, ss.94 - 99, 2022. 10.5152/j.aott.2022.21131
ISNAD	KALKISIM, Muhammet vd. "The mid-term clinical outcomes of total knee arthroplasty in the management of end-stage hemophilic arthropathy". Acta Orthopaedica et Traumatologica Turcica 56/2 (2022), 94-99. https://doi.org/10.5152/j.aott.2022.21131